Sai Life Sciences Limited — Important, 20-06-2025: General Updates

Sai Life Sciences has announced a board meeting to approve the financial results for the quarter and half-year. The company has successfully started commercial operations of the second phase of its Unit IV Bidar Facility, adding ≈91 kL capacity. This completes the planned ≈195 kL capacity expansion, bringing total capacity at Bidar to ≈640 kL. The expanded facility will produce Registered Starting Materials, intermediates, and APIs for clinical and commercial use, strengthening its manufacturing capabilities and potential revenue streams.